The global burden of degenerative mitral valve disease is rising annually, highlighting the need for targeted screening at age 65 and sex-stratified public health interventions.
May warrant DMVD screening at age 65 with sex-specific strategies; extends epidemiological evidence and informs targeted research.
No takes yet. Share an insight, caveat, or question.
Si et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: